Año: 2012
Journal Impact Factor (JIF): 9.3740
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
IMMUNOLOGY | SCIE | 9/137 | Q1 | T1 | D1 |
INFECTIOUS DISEASES | SCIE | 2/70 | Q1 | T1 | D1 |
MICROBIOLOGY | SCIE | 7/116 | Q1 | T1 | D1 |
Año: 2017
Journal Citation Indicator (JCI): 2,590
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
IMMUNOLOGY | 8/173 | Q1 | T1 | D1 | 95,67 |
INFECTIOUS DISEASES | 3/111 | Q1 | T1 | D1 | 97,75 |
MICROBIOLOGY | 7/145 | Q1 | T1 | D1 | 95,52 |
Año:
2012
CiteScore:
15,300
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
General Medicine | 103/3199 | Q1 | T1 | D1 |
Infectious Diseases | 6/230 | Q1 | T1 | D1 |
Microbiology (medical) | 2/96 | Q1 | T1 | D1 |
SJR año:
2012
Factor de Impacto:
4,573
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Infectious Diseases | 6/288 | Q1 | T1 | D1 |
Microbiology (medical) | 3/119 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
Abbott | - |
Boehringer-Ingelheim | - |
Bristol-Myers Squibb | - |
Gilead | - |
Gilead Sciences | - |
GlaxoSmithKline | - |
Janssen Pharmaceutica | - |
Johnson Johnson | - |
Medical Research Council | MR/J002380/1; G0900274 |
Merck-Sharp Dohme-Chibret | - |
National Institute for Health Research | NF-SI-0611-10168 |
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES | R01AI073127 |
NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM | U10AA013566 |
National Institutes of Health | R01-AI073127; U10-AA013566 |
Pfizer | - |
Roche | - |
Tibotec | - |
Tibotec-Janssen | - |
ViiV Healthcare | - |
# | Autor |
---|---|
1 | |
2 | Moreno, S |
3 | Bucher, HC |
4 | Furrer, H |
5 | Logan, R |
6 | Sterne, J |
7 | Perez-Hoyos, S |
8 | Jarrin, I |
9 | Phillips, A |
10 | Lodi, S |
11 | van Sighem, A |
12 | de Wolf, F |
13 | Sabin, C |
14 | Bansi, L |
15 | Justice, A |
16 | Goulet, J |
17 | Miro, JM |
18 | Ferrer, E |
19 | Meyer, L |
20 | Seng, R |
21 | Toulomi, G |
22 | Gargalianos, P |
23 | Costagliola, D |
24 | Abgrall, S |
25 | Hernan, MA |
# | Autoría grupal |
1 | López Cortés, Luis Fernando (HIV-CAUSAL Collaboration) |